Eli Lilly transfers sole China rights for its cancer drug to a local partner, and the timing points to a looming problem ahead of the pharma giant.
Eli Lilly's next leg of growth may have less to do with how well its weight loss drugs work and more to do with how many ...
Eli Lilly (LLY) is back in focus after handing Chinese partner Innovent Biologics full commercial control of breast cancer ...
4don MSN
Is it too late to buy Eli Lilly stock? Here's what $1,000 invested today could be worth in 10 years.
The stock has surged 160% over the past three years. Meanwhile, two key drugs could continue driving rampant growth.
As the 2026 Winter Olympics get underway in Italy this week, Eli Lilly—a partner of both Team USA and the Milan Cortina Games as a whole—is rolling out a new corporate campaign inspired by the event.
Abbisko Therapeutics Co., Ltd. on Tuesday announced a new strategic research collaboration and license agreement with Eli ...
Eli Lilly stock draws attention as strong drug demand supports cash flow, while rich earnings valuation keeps market debate ...
Eli Lilly draws fresh market attention as healthcare rotation, GLP treatment access, and obesity care demand strengthen its ...
In the latest China pharmaceutical industry collaboration pact with a global drug leader, Abbisko said today it will work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results